Pearls of wisdom for aspiring physician-scientist residency applicants and program directors.


Journal

JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073

Informations de publication

Date de publication:
22 03 2022
Historique:
entrez: 22 3 2022
pubmed: 23 3 2022
medline: 12 4 2022
Statut: epublish

Résumé

Postgraduate physician-scientist training programs (PSTPs) enhance the experiences of physician-scientist trainees following medical school graduation. PSTPs usually span residency and fellowship training, but this varies widely by institution. Applicant competitiveness for these programs would be enhanced, and unnecessary trainee anxiety relieved, by a clear understanding of what factors define a successful PSTP matriculant. Such information would also be invaluable to PSTP directors and would allow benchmarking of their admissions processes with peer programs. We conducted a survey of PSTP directors across the US to understand the importance they placed on components of PSTP applications. Of 41 survey respondents, most were from internal medicine and pediatrics residency programs. Of all components in the application, two elements were considered very important by a majority of PSTP directors: (a) having one or more first-author publications and (b) the thesis advisor's letter. Less weight was consistently placed on factors often considered more relevant for non-physician-scientist postgraduate applicants - such as US Medical Licensing Examination scores, awards, and leadership activities. The data presented here highlight important metrics for PSTP applicants and directors and suggest that indicators of scientific productivity and commitment to research outweigh traditional quantitative measures of medical school performance.

Identifiants

pubmed: 35315364
pii: 158467
doi: 10.1172/jci.insight.158467
pmc: PMC8986063
doi:
pii:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : BLRD VA
ID : I01 BX001426
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG036675
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK123704
Pays : United States
Organisme : NIA NIH HHS
ID : T35 AG067577
Pays : United States

Références

Acad Med. 2013 Nov;88(11):1747-53
pubmed: 24072121
Am J Med. 2018 May;131(5):578-584
pubmed: 29410155
Eval Health Prof. 2016 Mar;39(1):3-20
pubmed: 24686746
JCI Insight. 2019 Oct 3;4(19):
pubmed: 31578310
Acad Med. 2009 Apr;84(4):468-71
pubmed: 19318780
Acad Med. 2017 Oct;92(10):1390-1398
pubmed: 28658019
JCI Insight. 2018 Dec 6;3(23):
pubmed: 30518696
Am J Med Sci. 2021 Jan;361(1):23-29
pubmed: 33288205
Front Med (Lausanne). 2020 Sep 22;7:579100
pubmed: 33072789
J Pediatr. 2022 Feb;241:5-9.e3
pubmed: 34280401

Auteurs

Emily J Gallagher (EJ)

Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Don C Rockey (DC)

Division of Gastroenterology and Hepatology and Digestive Disease Research Center, Medical University of South Carolina, Charleston, South Carolina, USA.

Christopher D Kontos (CD)

Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.

Jatin M Vyas (JM)

Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Lawrence F Brass (LF)

Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Patrick J Hu (PJ)

Departments of Medicine and Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Carlos M Isales (CM)

Departments of Medicine, Neuroscience and Regenerative Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia, USA.

Olujimi A Ajijola (OA)

UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles City, California, USA.

W Kimryn Rathmell (WK)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Paul R Conlin (PR)

VA Boston Healthcare System and Harvard Medical School, Boston, Massachusetts, USA.

Robert A Baiocchi (RA)

Division of Hematology, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

Barbara I Kazmierczak (BI)

Department of Microbial Pathogenesis, Department of Medicine (Infectious Diseases), Yale University School of Medicine, New Haven, Connecticut, USA.

Myles H Akabas (MH)

Departments of Physiology and Biophysics, Neuroscience, and Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

Christopher S Williams (CS)

Department of Medicine, Division of Gastroenterology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Veterans Affairs Tennessee Valley Health Care System, Nashville, Tennessee, USA; Vanderbilt Ingram Cancer Center, Nashville, Tennessee, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH